JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Unlocking the potential: FKK6 as a microbial mimicry-based therapy for chronic inflammation-associated colorectal cancer in a murine model

  • 0Department of Cell Biology and Genetics, Faculty of Science, Palacký University, Olomouc, Czech Republic.
The Journal of Pharmacology and Experimental Therapeutics +

|

March 1, 2025

|

March 1, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Felix Kopp Kortagere 6 (FKK6), a microbial metabolite mimic, demonstrated significant antitumor effects in a colitis-associated colon cancer mouse model. Chronic toxicity and genotoxicity studies confirmed FKK6

Area Of Science

  • Gastroenterology and Oncology
  • Pharmacology and Drug Discovery

Background

  • Chronic intestinal inflammation is a key driver of colorectal cancer development.
  • Novel therapeutic strategies are needed to combat colitis-associated colon cancer (CAC).
  • Microbial metabolite mimics offer a potential new drug development paradigm.

Purpose Of The Study

  • To evaluate the therapeutic potential of Felix Kopp Kortagere 6 (FKK6) in a murine model of colitis-associated colon cancer (CAC).
  • To assess the safety and toxicity profile of FKK6 through chronic administration and in vitro testing.

Main Methods

  • FKK6 efficacy was tested in an azoxymethane and dextran sodium sulfate (DSS)-induced CAC mouse model.
  • Chronic toxicity was evaluated over 30 days in mice.
  • Genotoxicity was assessed using Ames and micronucleus tests.
  • Metabolomic analysis of fecal samples was performed.

Main Results

  • FKK6 significantly reduced colon tumor size and number, improved histopathology, and decreased tumor marker expression.
  • No significant chronic toxicity or genotoxic/mutagenic potential was observed.
  • Fecal metabolome analysis showed no significant alterations.

Conclusions

  • FKK6 exhibits significant anticancer effects in a preclinical model of CAC.
  • FKK6 demonstrates a favorable safety profile, with no observed chronic toxicity or genotoxicity.
  • FKK6 is a promising candidate for further development as a therapeutic agent for CAC.

Keywords: